Jill Schiaparelli, MBA
CEO & President, Co Founder, Member Board Of Directors @ Avation Medical
Jill Schiaparelli CEO Profile
Jill Schiaparelli serves as the CEO and a member of the board of directors, and is also a co-founder of her current organization. With over 20 years of experience in the healthcare industry, she has a strong background in leadership roles, having worked with major companies like Johnson & Johnson and Baxter. Her expertise spans across global medical device commercialization, emerging technologies, strategic marketing, healthcare consumerism, and patient care pathway modeling.
Jill Schiaparelli Education Background
Jill Schiaparelli holds an MBA in Finance and Business Management from the Stern School of Business at New York University. Additionally, she earned a BS in Finance and International Management from the Questrom School of Business at Boston University. Her educational background has equipped her with a robust understanding of finance and business management, which she has effectively applied throughout her career in various leadership roles.
Jill Schiaparelli Healthcare Industry Experience
With a career spanning more than two decades, Jill Schiaparelli has garnered extensive experience in the healthcare sector. She has previously held key positions at Johnson & Johnson and Baxter, where she specialized in roles that focused on global medical device commercialization and strategic marketing. Her work with ApaTech (UK), which she helped sell to Baxter, stands as a notable highlight of her career.
Jill Schiaparelli Leadership in Emerging Technologies
Jill Schiaparelli has a proven track record in leading projects focused on emerging technologies. She played a pivotal role at InteloMed in launching the CVInsight™ Monitoring and Informatics System. Additionally, she has been involved with the Neurotechnology Innovations Translator, an incubator and investment vehicle for companies in the neuromodulation space. Her strategic marketing insights and focus on patient care pathway modeling have driven innovation in the healthcare technology sector.
Jill Schiaparelli Contributions to AxoGen and NASDAQ Uplisting
Jill Schiaparelli contributed significantly to AxoGen's success, assisting the company in its up-list to NASDAQ. Her experience in strategic marketing and finance was instrumental in navigating the complexities of such a significant move. Her role in this achievement underscores her capability in steering companies through crucial growth phases.
